3 Supercharged Growth Stocks With 126% to 248% Upside, According to Wall Street_老虎社区_美港股上老虎

3 Supercharged Growth Stocks With 126% to 248% Upside, According to Wall Street

Motley Fool2022-02-18

Whether you realize it or not, stock market corrections, and even crashes, are an inevitable part of the investing cycle. Over the past six-plus weeks, the broader market has undergone its steepest ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

bobbylim
·2022-02-18
Lfg!
回复
点赞
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2212134336?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2022-02-18 08:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2212134336","market":"us","top_or_hot":-1,"title":"3 Supercharged Growth Stocks With 126% to 248% Upside, According to Wall Street","media":"Motley Fool","content":"<div>\n<p>Whether you realize it or not, stock market corrections, and even crashes, are an inevitable part of the investing cycle. Over the past six-plus weeks, the broader market has undergone its steepest ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/02/17/3-growth-stocks-with-126-to-248-upside-wall-street/\">网页链接</a>\n\n</div>\n","source":"fool_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Supercharged Growth Stocks With 126% to 248% Upside, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Supercharged Growth Stocks With 126% to 248% Upside, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-18 08:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/02/17/3-growth-stocks-with-126-to-248-upside-wall-street/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Whether you realize it or not, stock market corrections, and even crashes, are an inevitable part of the investing cycle. Over the past six-plus weeks, the broader market has undergone its steepest ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/02/17/3-growth-stocks-with-126-to-248-upside-wall-street/\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ETSY","symbol_name":"Etsy, Inc.","start_time":0,"source_url":"https://www.fool.com/investing/2022/02/17/3-growth-stocks-with-126-to-248-upside-wall-street/","article_id":"2212134336","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2212134336","pubTimestamp":1645143542,"columns":[],"sourceInfo":{"source_id":"fool_stock","name":"Motley Fool"},"weMediaInfo":null,"summary":"If select analysts are correct, these rapidly growing companies could bounce back big time.","collect":0,"end_time":0,"defaultTopTitle":"fool.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"ETSY":"Etsy, Inc.","BK4108":"电影和娱乐","BK4535":"淡马锡持仓","BK4548":"巴美列捷福持仓","BK4139":"生物科技","BK4507":"流媒体概念","BK4551":"寇图资本持仓","BK4568":"美国抗疫概念","BNTX":"BioNTech SE","ROKU":"Roku Inc","NVAX":"诺瓦瓦克斯医药","BK4532":"文艺复兴科技持仓","BK4122":"互联网与直销零售","BK4524":"宅经济概念"},"translate_title":"华尔街数据显示，3只增长强劲的股票上涨幅度在126%至248%之间","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ETSY":1,"NVAX":1,"ROKU":1,"BNTX":0.9},"content_text":"Whether you realize it or not, stock market corrections, and even crashes, are an inevitable part of the investing cycle. Over the past six-plus weeks, the broader market has undergone its steepest decline since the initial wave of the coronavirus pandemic in March 2020.But when volatility picks up, opportunity knocks for long-term investors. Every single crash or correction throughout history has eventually been erased by a bull-market rally. This means great businesses may be trading at a discount right now.According to a select group of analysts and investment banks, the latest correction could yield massive upside for a trio of supercharged growth stocks. If Wall Street's high-water price targets come to fruition, these fast-paced companies could rocket higher by 126% to as much as 248% over the next 12 months.Etsy: Implied upside of 126%First up is e-commerce platform Etsy (NASDAQ:ETSY), which has grown its sales from around $600 million in 2018 to an expected $2.3 billion in 2021. According to Nicholas Jones of Citigroup, Etsy has the potential to reach $320 a share, which would represent upside of up to 126% over the coming year.If there's a prevailing concern about the company, it's undoubtedly what growth might look like after the pandemic ends. It's no secret that Etsy benefited immensely from the COVID-19 pandemic.Lockdowns during the initial waves coerced more people than ever to buy products online. This included face coverings, which provided a tangible boost to the total gross merchandise sales traversing the platform. The fear is that once the pandemic ends, Etsy's sales growth will slow and its valuation multiple will contract.But Etsy has three catalysts working in its favor that suggest $320 is a possibility -- probably not within a year, but at some point in the future.To begin with, consumers have continually spent more online over the past decade. According to Digital Commerce 360, annual year-over-year online sales growth has ranged between 12.6% and 15.6% since 2012, with one exception -- 2020, which saw 31.8% year-over-year sales growth. This bodes well for Etsy's online marketplace.Second, Etsy does a fantastic job of personalizing its platform. Etsy's marketplace is comprised of small merchants, and many of them produce unique or customized products. This distinction means the company doesn't have many direct competitors.And third, it's effectively converting casual shoppers into habitual buyers. A habitual buyer makes six or more purchases over 12 months and spends at least $200. In the September-ended quarter, the number of habitual buyers soared 65% from the prior-year period. Merchants will spend big to get their ads in front of these habitual buyers; this is ultimately what can push Etsy's share price to $320.Roku: Implied upside of 235%Another supercharged growth stock with enormous upside, at least according to one Wall Street analyst, is television-streaming platform Roku (NASDAQ:ROKU). Based on the $550 price target issued by Tom Forte of DA Davidson, Roku offers upside of 235% over the coming 12 months.Though $550 is a big number, investors should realize that Roku has retraced significantly from its all-time high of $490.76 (it closed this past weekend at $163.94). This weakness seems to be caused by the Federal Reserve and rapidly rising inflation.Roku has been hurt in the short term by slowing sales of smart TVs, which have become pricier. Additionally, valuation multiples for growth stocks often contract when the Federal Reserve enters a monetary-tightening cycle. While these near-term concerns are weighing on Roku, there are two seemingly unstoppable trends working in the company's favor.One would be America's consistent cord-cutting. Based on data from NScreenMedia.com, the number of U.S. households with cable, satellite, or telcoTV services has plummeted by over 21 million to 75.6 million in a four-year time frame. Comparatively, the number of U.S. households without any of these traditional services has increased to over 50 million.These figures clearly show that consumers want to dictate their content packages, rather than have cable companies offer take-it-or-leave-it-styled bundles. With free and paid content options, Roku users are being given the choices they crave.The second unstoppable trend that'll benefit Roku even more than cord-cutting is the ongoing shift to digital programmatic ads. As consumers push away from traditional cable and satellite providers and toward connected TV/over-the-top solutions, advertisers are adjusting how they reach users. Roku's growing user base is giving the company more pricing power with advertisers, which is resulting in significantly higher average revenue per user, despite slower user growth in the past couple of quarters.As long as these two trends continue -- and there's no indication they won't -- Roku has an opportunity to head much higher over the long run.Novavax: Implied upside of 248%The third supercharged growth stock with incredible upside over the next 12 months is biotech-stock Novavax (NASDAQ:NVAX). The high-water price target on Novavax comes from analyst Mayank Mamtani of B. Riley, who believes shares can reach $315. This would represent a cool 248% increase.But similar to Roku, Novavax's share price has fallen off a cliff recently. Less than two months ago, shares were as high as $236, on an intraday basis. This past weekend, they closed at $90. Investors have been concerned with the company's delayed emergency-use authorization (EUA) filings for its COVID-19 vaccine, NVX-CoV2373, as well as its slow vaccine production ramp-up.What's important to recognize is that both of these issues can be resolved in mere months. In fact, Novavax has filed for EUA or been granted approval in a number of key markets worldwide since the beginning of November.Another key selling point for Novavax is the efficacy of its COVID-19 vaccine. To date, three major studies have been run. In March and June of last year, the company unveiled the results of two large studies in the U.K. and U.S./Mexico that produced respective vaccine efficacies of 89.7% and 90.4%. More recently, the company announced an 82% vaccine efficacy in adolescents against the delta variant.The point is that only three vaccines have hit the 90% vaccine efficacy mark, and Novavax's NVX-CoV2373 is one of them. This should allow the company to become a leader in the global-inoculation campaign.It's also looking likely that COVID-19 will be deemed an endemic illness. Instead of Novavax benefiting from a one-time sales pop, it has an opportunity to be a leader in providing booster shots, variant-specific vaccines, and maybe even combination vaccines (e.g., influenza and COVID-19). In other words, Novavax is potentially sitting on a recurring revenue gold mine.While $315 might be asking a bit much over the next year, it's a very reasonable multiyear price target, given NVX-CoV2373's global potential.","kind":"highlight","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":638807856,"gmtCreate":1645162778577,"gmtModify":1645162778848,"author":{"id":"3575499385722971","authorId":"3575499385722971","name":"bobbylim","avatar":"https://static.tigerbbs.com/1d9753dcafa04623c0e98c0bcaa291ae","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3575499385722971","authorIdStr":"3575499385722971"},"htmlText":"Lfg!","listText":"Lfg!","text":"Lfg!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/638807856","repostId":2212134336,"repostType":4,"repost":{"id":"2212134336","kind":"highlight","pubTimestamp":1645143542,"share":"https://www.laohu8.com/m/news/2212134336?lang=&edition=full","pubTime":"2022-02-18 08:19","market":"us","language":"en","title":"3 Supercharged Growth Stocks With 126% to 248% Upside, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2212134336","media":"Motley Fool","summary":"If select analysts are correct, these rapidly growing companies could bounce back big time.","content":"<html><head></head><body><p>Whether you realize it or not, stock market corrections, and even crashes, are an inevitable part of the investing cycle. Over the past six-plus weeks, the broader market has undergone its steepest decline since the initial wave of the coronavirus pandemic in March 2020.</p><p>But when volatility picks up, opportunity knocks for long-term investors. Every single crash or correction throughout history has eventually been erased by a bull-market rally. This means great businesses may be trading at a discount right now.</p><p>According to a select group of analysts and investment banks, the latest correction could yield massive upside for a trio of supercharged growth stocks. If Wall Street&#39;s high-water price targets come to fruition, these fast-paced companies could rocket higher by 126% to as much as 248% over the next 12 months.</p><h2>Etsy: Implied upside of 126%</h2><p>First up is e-commerce platform <b>Etsy</b> (NASDAQ:ETSY), which has grown its sales from around $600 million in 2018 to an expected $2.3 billion in 2021. According to Nicholas Jones of <b>Citigroup</b>, Etsy has the potential to reach $320 a share, which would represent upside of up to 126% over the coming year.</p><p>If there&#39;s a prevailing concern about the company, it&#39;s undoubtedly what growth might look like after the pandemic ends. It&#39;s no secret that Etsy benefited immensely from the COVID-19 pandemic.</p><p>Lockdowns during the initial waves coerced more people than ever to buy products online. This included face coverings, which provided a tangible boost to the total gross merchandise sales traversing the platform. The fear is that once the pandemic ends, Etsy&#39;s sales growth will slow and its valuation multiple will contract.</p><p>But Etsy has three catalysts working in its favor that suggest $320 is a possibility -- probably not within a year, but at some point in the future.</p><p>To begin with, consumers have continually spent more online over the past decade. According to Digital Commerce 360, annual year-over-year online sales growth has ranged between 12.6% and 15.6% since 2012, with <a href=\"https://laohu8.com/S/AONE.U\">one</a> exception -- 2020, which saw 31.8% year-over-year sales growth. This bodes well for Etsy&#39;s online marketplace.</p><p>Second, Etsy does a fantastic job of personalizing its platform. Etsy&#39;s marketplace is comprised of small merchants, and many of them produce unique or customized products. This distinction means the company doesn&#39;t have many direct competitors.</p><p>And third, it&#39;s effectively converting casual shoppers into habitual buyers. A habitual buyer makes six or more purchases over 12 months and spends at least $200. In the September-ended quarter, the number of habitual buyers soared 65% from the prior-year period. Merchants will spend big to get their ads in front of these habitual buyers; this is ultimately what can push Etsy&#39;s share price to $320.</p><h2>Roku: Implied upside of 235%</h2><p>Another supercharged growth stock with enormous upside, at least according to one Wall Street analyst, is television-streaming platform <b>Roku</b> (NASDAQ:ROKU). Based on the $550 price target issued by Tom Forte of DA Davidson, Roku offers upside of 235% over the coming 12 months.</p><p>Though $550 is a big number, investors should realize that Roku has retraced significantly from its all-time high of $490.76 (it closed this past weekend at $163.94). This weakness seems to be caused by the Federal Reserve and rapidly rising inflation.</p><p>Roku has been hurt in the short term by slowing sales of smart TVs, which have become pricier. Additionally, valuation multiples for growth stocks often contract when the Federal Reserve enters a monetary-tightening cycle. While these near-term concerns are weighing on Roku, there are two seemingly unstoppable trends working in the company&#39;s favor.</p><p>One would be America&#39;s consistent cord-cutting. Based on data from NScreenMedia.com, the number of U.S. households with cable, satellite, or telcoTV services has plummeted by over 21 million to 75.6 million in a four-year time frame. Comparatively, the number of U.S. households without any of these traditional services has increased to over 50 million.</p><p>These figures clearly show that consumers want to dictate their content packages, rather than have cable companies offer take-it-or-leave-it-styled bundles. With free and paid content options, Roku users are being given the choices they crave.</p><p>The second unstoppable trend that&#39;ll benefit Roku even more than cord-cutting is the ongoing shift to digital programmatic ads. As consumers push away from traditional cable and satellite providers and toward connected TV/over-the-top solutions, advertisers are adjusting how they reach users. Roku&#39;s growing user base is giving the company more pricing power with advertisers, which is resulting in significantly higher average revenue per user, despite slower user growth in the past couple of quarters.</p><p>As long as these two trends continue -- and there&#39;s no indication they won&#39;t -- Roku has an opportunity to head much higher over the long run.</p><h2>Novavax: Implied upside of 248%</h2><p>The third supercharged growth stock with incredible upside over the next 12 months is biotech-stock <b>Novavax</b> (NASDAQ:NVAX). The high-water price target on Novavax comes from analyst Mayank Mamtani of B. Riley, who believes shares can reach $315. This would represent a cool 248% increase.</p><p>But similar to Roku, Novavax&#39;s share price has fallen off a cliff recently. Less than two months ago, shares were as high as $236, on an intraday basis. This past weekend, they closed at $90. Investors have been concerned with the company&#39;s delayed emergency-use authorization (EUA) filings for its COVID-19 vaccine, NVX-CoV2373, as well as its slow vaccine production ramp-up.</p><p>What&#39;s important to recognize is that both of these issues can be resolved in mere months. In fact, Novavax has filed for EUA or been granted approval in a number of key markets worldwide since the beginning of November.</p><p>Another key selling point for Novavax is the efficacy of its COVID-19 vaccine. To date, three major studies have been run. In March and June of last year, the company unveiled the results of two large studies in the U.K. and U.S./Mexico that produced respective vaccine efficacies of 89.7% and 90.4%. More recently, the company announced an 82% vaccine efficacy in adolescents against the delta variant.</p><p>The point is that only three vaccines have hit the 90% vaccine efficacy mark, and Novavax&#39;s NVX-CoV2373 is one of them. This should allow the company to become a leader in the global-inoculation campaign.</p><p>It&#39;s also looking likely that COVID-19 will be deemed an endemic illness. Instead of Novavax benefiting from a one-time sales pop, it has an opportunity to be a leader in providing booster shots, variant-specific vaccines, and maybe even combination vaccines (e.g., influenza and COVID-19). In other words, Novavax is potentially sitting on a recurring revenue gold mine.</p><p>While $315 might be asking a bit much over the next year, it&#39;s a very reasonable multiyear price target, given NVX-CoV2373&#39;s global potential.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Supercharged Growth Stocks With 126% to 248% Upside, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Supercharged Growth Stocks With 126% to 248% Upside, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-18 08:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/02/17/3-growth-stocks-with-126-to-248-upside-wall-street/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Whether you realize it or not, stock market corrections, and even crashes, are an inevitable part of the investing cycle. Over the past six-plus weeks, the broader market has undergone its steepest ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/02/17/3-growth-stocks-with-126-to-248-upside-wall-street/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4568":"美国抗疫概念","BK4532":"文艺复兴科技持仓","ROKU":"Roku Inc","NVAX":"诺瓦瓦克斯医药","BK4122":"互联网与直销零售","BK4535":"淡马锡持仓","BK4551":"寇图资本持仓","BK4524":"宅经济概念","BK4548":"巴美列捷福持仓","BK4108":"电影和娱乐","ETSY":"Etsy, Inc.","BK4507":"流媒体概念","BNTX":"BioNTech SE","BK4139":"生物科技"},"source_url":"https://www.fool.com/investing/2022/02/17/3-growth-stocks-with-126-to-248-upside-wall-street/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2212134336","content_text":"Whether you realize it or not, stock market corrections, and even crashes, are an inevitable part of the investing cycle. Over the past six-plus weeks, the broader market has undergone its steepest decline since the initial wave of the coronavirus pandemic in March 2020.But when volatility picks up, opportunity knocks for long-term investors. Every single crash or correction throughout history has eventually been erased by a bull-market rally. This means great businesses may be trading at a discount right now.According to a select group of analysts and investment banks, the latest correction could yield massive upside for a trio of supercharged growth stocks. If Wall Street's high-water price targets come to fruition, these fast-paced companies could rocket higher by 126% to as much as 248% over the next 12 months.Etsy: Implied upside of 126%First up is e-commerce platform Etsy (NASDAQ:ETSY), which has grown its sales from around $600 million in 2018 to an expected $2.3 billion in 2021. According to Nicholas Jones of Citigroup, Etsy has the potential to reach $320 a share, which would represent upside of up to 126% over the coming year.If there's a prevailing concern about the company, it's undoubtedly what growth might look like after the pandemic ends. It's no secret that Etsy benefited immensely from the COVID-19 pandemic.Lockdowns during the initial waves coerced more people than ever to buy products online. This included face coverings, which provided a tangible boost to the total gross merchandise sales traversing the platform. The fear is that once the pandemic ends, Etsy's sales growth will slow and its valuation multiple will contract.But Etsy has three catalysts working in its favor that suggest $320 is a possibility -- probably not within a year, but at some point in the future.To begin with, consumers have continually spent more online over the past decade. According to Digital Commerce 360, annual year-over-year online sales growth has ranged between 12.6% and 15.6% since 2012, with one exception -- 2020, which saw 31.8% year-over-year sales growth. This bodes well for Etsy's online marketplace.Second, Etsy does a fantastic job of personalizing its platform. Etsy's marketplace is comprised of small merchants, and many of them produce unique or customized products. This distinction means the company doesn't have many direct competitors.And third, it's effectively converting casual shoppers into habitual buyers. A habitual buyer makes six or more purchases over 12 months and spends at least $200. In the September-ended quarter, the number of habitual buyers soared 65% from the prior-year period. Merchants will spend big to get their ads in front of these habitual buyers; this is ultimately what can push Etsy's share price to $320.Roku: Implied upside of 235%Another supercharged growth stock with enormous upside, at least according to one Wall Street analyst, is television-streaming platform Roku (NASDAQ:ROKU). Based on the $550 price target issued by Tom Forte of DA Davidson, Roku offers upside of 235% over the coming 12 months.Though $550 is a big number, investors should realize that Roku has retraced significantly from its all-time high of $490.76 (it closed this past weekend at $163.94). This weakness seems to be caused by the Federal Reserve and rapidly rising inflation.Roku has been hurt in the short term by slowing sales of smart TVs, which have become pricier. Additionally, valuation multiples for growth stocks often contract when the Federal Reserve enters a monetary-tightening cycle. While these near-term concerns are weighing on Roku, there are two seemingly unstoppable trends working in the company's favor.One would be America's consistent cord-cutting. Based on data from NScreenMedia.com, the number of U.S. households with cable, satellite, or telcoTV services has plummeted by over 21 million to 75.6 million in a four-year time frame. Comparatively, the number of U.S. households without any of these traditional services has increased to over 50 million.These figures clearly show that consumers want to dictate their content packages, rather than have cable companies offer take-it-or-leave-it-styled bundles. With free and paid content options, Roku users are being given the choices they crave.The second unstoppable trend that'll benefit Roku even more than cord-cutting is the ongoing shift to digital programmatic ads. As consumers push away from traditional cable and satellite providers and toward connected TV/over-the-top solutions, advertisers are adjusting how they reach users. Roku's growing user base is giving the company more pricing power with advertisers, which is resulting in significantly higher average revenue per user, despite slower user growth in the past couple of quarters.As long as these two trends continue -- and there's no indication they won't -- Roku has an opportunity to head much higher over the long run.Novavax: Implied upside of 248%The third supercharged growth stock with incredible upside over the next 12 months is biotech-stock Novavax (NASDAQ:NVAX). The high-water price target on Novavax comes from analyst Mayank Mamtani of B. Riley, who believes shares can reach $315. This would represent a cool 248% increase.But similar to Roku, Novavax's share price has fallen off a cliff recently. Less than two months ago, shares were as high as $236, on an intraday basis. This past weekend, they closed at $90. Investors have been concerned with the company's delayed emergency-use authorization (EUA) filings for its COVID-19 vaccine, NVX-CoV2373, as well as its slow vaccine production ramp-up.What's important to recognize is that both of these issues can be resolved in mere months. In fact, Novavax has filed for EUA or been granted approval in a number of key markets worldwide since the beginning of November.Another key selling point for Novavax is the efficacy of its COVID-19 vaccine. To date, three major studies have been run. In March and June of last year, the company unveiled the results of two large studies in the U.K. and U.S./Mexico that produced respective vaccine efficacies of 89.7% and 90.4%. More recently, the company announced an 82% vaccine efficacy in adolescents against the delta variant.The point is that only three vaccines have hit the 90% vaccine efficacy mark, and Novavax's NVX-CoV2373 is one of them. This should allow the company to become a leader in the global-inoculation campaign.It's also looking likely that COVID-19 will be deemed an endemic illness. Instead of Novavax benefiting from a one-time sales pop, it has an opportunity to be a leader in providing booster shots, variant-specific vaccines, and maybe even combination vaccines (e.g., influenza and COVID-19). In other words, Novavax is potentially sitting on a recurring revenue gold mine.While $315 might be asking a bit much over the next year, it's a very reasonable multiyear price target, given NVX-CoV2373's global potential.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":8,"commentSize":1,"repostSize":0,"favoriteSize":1,"likeStatus":false,"favoriteStatus":false}}